{"ticker":"VERV","name":"Verve Therapeutics","sector":"Cardiovascular","total_score":10.13,"grade":"F","components":{"publication":1.0,"clinical_trial":0.0833},"calculated_at":"2026-10-20 07:00:03.207799","latest_signals":[{"signal_type":"clinical_trial","score":0.19000000000000003,"data":{"as_of":"2026-10-17","total":3,"phase1":2,"phase2":0,"phase3":0,"phase4":0,"source_type":"clinicaltrials.gov","source_url":"https://clinicaltrials.gov/","public_gate":"fresh_clinicaltrials_aggregate"},"created_at":"2026-10-17 03:30:03.406825"},{"signal_type":"publication","score":1.0,"data":{"description":"5 linked PubMed record(s) matched the source query.","search_term":"Verve","recent_articles":[{"url":"https://pubmed.ncbi.nlm.nih.gov/42720632/","pmid":"42720632","title":"Reduced use of skin testing in the evaluation of antibiotic allergy in the United States.","source":"J Allergy Clin Immunol","authors":"Blumenthal KG","pubdate":"2026 Sep 9"},{"url":"https://pubmed.ncbi.nlm.nih.gov/42671478/","pmid":"42671478","title":"Trials and tribulations of spironolactone in heart failure with preserved ejection fraction: Insights from the SPIRIT-HF trial.","source":"Heart Fail Rev","authors":"Basile C","pubdate":"2026 Aug 31"},{"url":"https://pubmed.ncbi.nlm.nih.gov/42669300/","pmid":"42669300","title":"Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.","source":"Lancet","authors":"Silvain J","pubdate":"2026 Sep 19"},{"url":"https://pubmed.ncbi.nlm.nih.gov/42669075/","pmid":"42669075","title":"Effect of In-Hospital Initiation of Dapagliflozin on Decongestion in Patients Hospitalized for Heart Failure: An Analysis of the DAPA ACT HF-TIMI 68 Trial.","source":"JACC Heart Fail","authors":"Small AM","pubdate":"2026 Aug 30"},{"url":"https://pubmed.ncbi.nlm.nih.gov/42610264/","pmid":"42610264","title":"Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial.","source":"Circulation","authors":"Bonaca MP","pubdate":"2026 Sep 15"}],"total_publications":5,"source_type":"PubMed","source_url":"https://pubmed.ncbi.nlm.nih.gov/","public_gate":"linkable_pubmed_article_required"},"created_at":"2026-09-23 05:07:58.833961"}],"signal_counts":{"clinical_trial":1,"publication":1},"ticker_status":null}